LDLR-Mediated Targeting and Productive Uptake of siRNA-Peptide Ligand Conjugates In Vitro and In Vivo

Archive ouverte

Broc, Baptiste | Varini, Karine | Sonnette, Rose | Pecqueux, Belinda | Benoist, Florian | Masse, Maxime | Mechioukhi, Yasmine | Ferracci, Géraldine | Temsamani, Jamal | Khrestchatisky, Michel | Jacquot, Guillaume | Lécorché, Pascaline

Edité par CCSD ; MDPI -

International audience. Small RNA molecules such as microRNA and small interfering RNA (siRNA) have become promising therapeutic agents because of their specificity and their potential to modulate gene expression. Any gene of interest can be potentially up- or down-regulated, making RNA-based technology the healthcare breakthrough of our era. However, the functional and specific delivery of siRNAs into tissues of interest and into the cytosol of target cells remains highly challenging, mainly due to the lack of efficient and selective delivery systems. Among the variety of carriers for siRNA delivery, peptides have become essential candidates because of their high selectivity, stability, and conjugation versatility. Here, we describe the development of molecules encompassing siRNAs against SOD1, conjugated to peptides that target the low-density lipoprotein receptor (LDLR), and their biological evaluation both in vitro and in vivo.

Suggestions

Du même auteur

Preparation and In Vitro Validation of a Cucurbit[7]uril-Peptide Conjugate Targeting the LDL Receptor

Archive ouverte | Yang, Xue | CCSD

International audience

Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier.

Archive ouverte | Molino, Yves | CCSD

International audience. The blood-brain barrier (BBB) prevents the entry of many drugs into the brain and, thus, is a major obstacle in the treatment of CNS diseases. There is some evidence that the LDL receptor (LD...

Optimization and in Vivo Validation of Peptide Vectors Targeting the LDL Receptor

Archive ouverte | Jacquot, Guillaume | CCSD

International audience. Active targeting and delivery to pathophysiological organs of interest is of paramount importance to increase specific accumulation of therapeutic drugs or imaging agents while avoiding syste...

Chargement des enrichissements...